ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma
10.1186/bcr3054
Saved in:
Main Authors: | Banerjee, A., Wu, Z.-S., Qian, P., Kang, J., Pandey, V., Liu, D.-X., Zhu, T., Lobie, P.E. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/109193 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling
by: Banerjee, A., et al.
Published: (2014) -
Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells
by: Banerjee, A., et al.
Published: (2014) -
Prognostic significance of the expression of GFRα1, GFRα3 and Syndecan-3, Proteins binding ARTEMIN, In mammary carcinoma
by: Wu, Z.-S., et al.
Published: (2014) -
Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma
by: Pandey, V, et al.
Published: (2020) -
Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma
by: Zhang, M, et al.
Published: (2020)